Minims Prednisolondinatriumfosfaat Bausch Health Ireland (Prednisolone Sodium Phosphate)

Prednisolone sodium phosphate, the active ingredient in Minims Prednisolondinatriumfosfaat Bausch Health Ireland, is a corticosteroid presented as an ophthalmic solution for ocular use. It is employed to reduce inflammation in the eye and is indicated for patients with ocular inflammatory conditions.

GNH USA supplies Minims Prednisolondinatriumfosfaat Bausch Health Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant packaging for global distribution.

Prednisolone sodium phosphate is a glucocorticoid used to manage ocular inflammation.

- Post‑operative ocular inflammation: reduces swelling and discomfort after eye surgery. - Uveitis: controls intra‑ocular inflammation and prevents tissue damage. - Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergic reactions.

Prednisolone sodium phosphate may cause a range of ocular and systemic reactions.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision. - Increased intra‑ocular pressure. - Tearing or watery eyes. - Foreign body sensation. - Mild ocular discomfort.

Serious or Rare Side Effects: - Secondary ocular infection. - Cataract formation with prolonged use. - Glaucoma due to sustained pressure rise. - Severe allergic reaction (e.g., angio‑edema). - Systemic adrenal suppression from extensive absorption. - Corneal thinning or ulceration.

When using Prednisolone sodium phosphate, consider the following precautions.

- Assess intra‑ocular pressure: monitor patients with glaucoma risk. - Limit duration: use the lowest effective dose for the shortest time. - Avoid in viral eye infections: may exacerbate conditions like herpes simplex keratitis. - Monitor for systemic effects: especially in children or prolonged therapy. - Counsel patients on proper instillation technique to reduce contamination. - Store at room temperature: keep in the original container, protect from light and moisture.

Prednisolone sodium phosphate can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppression and HPA‑axis effects. - NSA‑ID eye drops: increased risk of corneal melting.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may diminish anti‑inflammatory efficacy. - Antibiotic eye drops: possible reduced absorption of either agent. - Antifungal eye drops: monitor for altered therapeutic response. - Beta‑blocker eye drops: watch for additive intra‑ocular pressure changes.